Sanuwave Health Reports Q3 2026 Revenue Decline Amid Lower UltraMIST System Sales
Sanuwave Health (SNWV) reported a significant decline in third-quarter revenue, totaling $8.6 million, a 24% decrease year-over-year. The downturn was primarily driven by a 73% collapse in UltraMIST system sales, which fell to $1.2 million from $4.4 million in the prior year. Management attributed this decline to industry-wide financial pressures and an influx of used systems entering the market as former customers close their operations. Despite the drop in equipment sales, the company's recurring applicator business showed resilience with a 15% increase in unit volume. However, the company swung to an operating loss of $1.1 million compared to a profit in the previous year. Financial stability was further pressured by $2.3 million in sales tax settlement payments and a breach of the fixed charge coverage ratio under its JPMorgan credit agreement, which required an amendment and waiver.
Tickers: $SNWV
Topics: Financial Results Operating Loss Revenue Decline UltraMIST System Sales